 Irvine, California -- Medical device company Ivantis has received $17 million in its second round of institutional venture capital investment.
Ivantis has created a scaffolding technology for the treatment of primary open angle glaucoma.
New Enterprise Associates and Delphi Ventures invested in the funding round. The company said it would use the financing to expand clinical activities for its medical device. |